Awareness and Perception of Potential Stem Cells Therapy for Diabetes Among Malaysians: A Pilot Study

Tan Chung Keat, Eugenie Tan Sin Sing, Kiran Kaur, Marjan Sadat Seghayat, Normina Ahmad Bustami, Farahnaz Amini, Sharmanee Thiagarajah: Awareness and Perception of Potential Stem Cells Therapy for Diabetes Among Malaysians: A Pilot Study. 2019, (Type: POSTER PRESENTATION; Organisation: School of Healthy Aging, Medical Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Science, UCSI University, Kuala Lumpur Malaysia,).

Abstract

INTRODUCTION: Diabetes is a major global public health problem. According to International Diabetes Federation in 2017, nearly 3.5 million cases of diabetes reported in Malaysia. This metabolic disorder decreases insulin secretion due to impairment of ?-Langerhans cells of pancreas or insulin resistance causing raise in blood glucose level leading to other health complications. Many stem cells (SC) researches being pursued as a potential treatment for diabetes by finding an adequate supply of ?-Langerhans cells and protecting them from autoimmunity. The study aims to assess the awareness of SC and potential SC therapy for treating diabetes as well to assess the willingness to accept potential SC therapy among Putrajaya residents. METHODS: A cross-sectional study was conducted among 100 participants in Putrajaya aged 18 above through convenient sampling. RESULTS: Level of awareness on SC among Putrajaya residents, showed very significant association (p<0.001) with level of education, their willingness to store their SC and their perceptions of the ability of SC therapy to improve quality of life. Although majority of 70% respondents were supportive towards potential SC treatment, 77% of the respondents were not aware or unsure of potential SC therapy for diabetes while 50% of them unwilling to undergo diabetic treatment using SC. CONCLUSION: Currently FDA approved hematopoietic SC for the treatment of blood and immunological diseases, while many including SC treatment for diabetic still in research and clinical trials. Persistent efforts need to be taken systematically to create awareness on approved and clinical trial of SC therapy among Malaysian via various educational programmes

    BibTeX (Download)

    @proceedings{APCPH-2019-130,
    title = {Awareness and Perception of Potential Stem Cells Therapy for Diabetes Among Malaysians: A Pilot Study},
    author = {Tan Chung Keat and Eugenie Tan Sin Sing and Kiran Kaur and Marjan Sadat Seghayat and Normina Ahmad Bustami and Farahnaz Amini and Sharmanee Thiagarajah},
    year  = {2019},
    date = {2019-07-22},
    urldate = {2019-07-22},
    journal = {6th Asia-Pacific Conference on Public Health 2019 Proceedings},
    issue = {6},
    abstract = {INTRODUCTION: Diabetes is a major global public health problem. According to International Diabetes Federation in 2017, nearly 3.5 million cases of diabetes reported in Malaysia. This metabolic disorder decreases insulin secretion due to impairment of ?-Langerhans cells of pancreas or insulin resistance causing raise in blood glucose level leading to other health complications. Many stem cells (SC) researches being pursued as a potential treatment for diabetes by finding an adequate supply of ?-Langerhans cells and protecting them from autoimmunity. The study aims to assess the awareness of SC and potential SC therapy for treating diabetes as well to assess the willingness to accept potential SC therapy among Putrajaya residents. METHODS: A cross-sectional study was conducted among 100 participants in Putrajaya aged 18 above through convenient sampling. RESULTS: Level of awareness on SC among Putrajaya residents, showed very significant association (p\<0.001) with level of education, their willingness to store their SC and their perceptions of the ability of SC therapy to improve quality of life. Although majority of 70% respondents were supportive towards potential SC treatment, 77% of the respondents were not aware or unsure of potential SC therapy for diabetes while 50% of them unwilling to undergo diabetic treatment using SC. CONCLUSION: Currently FDA approved hematopoietic SC for the treatment of blood and immunological diseases, while many including SC treatment for diabetic still in research and clinical trials. Persistent efforts need to be taken systematically to create awareness on approved and clinical trial of SC therapy among Malaysian via various educational programmes},
    note = {Type: POSTER PRESENTATION; Organisation: School of Healthy Aging, Medical Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Science, UCSI University, Kuala Lumpur Malaysia,},
    keywords = {apcph2019, Awareness, diabetes, stem cell},
    pubstate = {published},
    tppubtype = {proceedings}
    }